As the field evolves, its crucial for healthcare leaders and organizations to stay agile, adapt to new trends, and focus on what matters most for patients and providers, namely: GLP1s are now firstline therapies: Adoption has accelerated from just 3% in 2021 to more than 23% in 2025, displacing longstanding generics like metformin
(Pharmacy quality matters even more for women using compounded semaglutide during menopause, where hormonal shifts affect dosing consistency.) It was time to cut through the noise
Dubbed the Ozempic baby boom, reports of surprise pregnancies from those on the treatment have spread
Abstract Although iron accumulates in brain regions impacted by neurodegenerative diseases such as Alzheimers and Parkinsons, how chronic elevated iron levels contribute to neuronal dysfunction remains unclear
Do many of the patients reporting gastroparesis already have diabetes (or pre-diabetes) and potential GI nerve damage from hyperglycemia
16S rDNA full-length assembly sequencing technology analysis of intestinal microbiome in polycystic ovary syndrome